Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pediatr Crit Care Med. 2017 Jul;18(7):731–732. doi: 10.1097/PCC.0000000000001214

Response to Letter to the Editor: (Micro)Nutrients as Therapy for MODS: Vitamin D and Others?

Katri Typpo 1, Allan Doctor 2
PMCID: PMC5650071  NIHMSID: NIHMS871856  PMID: 28691971

In proceedings from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Multiple Organ Dysfunction Syndrome (MODS) Workshop we discuss optimal macronutrient delivery with downstream maintenance of intestinal barrier functions and preserved intestinal microbiome diversity as promising therapies for pediatric MODS (1). The therapeutic opportunities for nutrients as a primary therapy for MODS is vast, and could be presented as its own conference. The focus of this conference was on optimal macronutrient delivery, which might then be a suitable platform for investigations to determine the influence of specific micronutrients and ‘pharmaconutrition’ on progression of organ dysfunction. In a letter to the editor, Dr. Suzuki and Dr. Berbel raise the intriguing question of universal vitamin D screening and supplementation during pediatric critical illness (2). In a recent systematic review of seven placebo-controlled, randomized clinical trials in adult ICU patients, vitamin D supplementation was associated with significantly lower mortality without adverse events, and the authors called for a large multi-center trial (3). While the preponderance of observational studies completed in pediatric critical illness demonstrate associations between severe vitamin D deficiency and more severe acute illness, some results are conflicting. McNally et.al., in 326 critically ill children, found that vitamin D deficiency was associated with increased length of stay and increased severity of illness (4). In contrast, Shah et.al., in 154 critically ill children with high prevalence of vitamin D deficiency, found no difference in mortality, length of stay, or severity of illness, but a decrease in acute respiratory distress syndrome in children with severe vitamin D deficiency when compared with critically ill children who were not deficient (5). Before making general recommendations, a meta-analysis or large epidemiological study examining the association between vitamin D deficiency status and pediatric outcomes is needed. Vitamin D deficiency is common during pediatric critical illness, but universal screening during pediatric critical illness would be indicated in the setting of proven benefit to supplementation or clear absence of harm. Supportive data exist for several micronutrients such as vitamin C, thiamine, and vitamin D, which present as deficiencies and offer potential targets to improve organ function (68). Micronutrient supplementation at high dose or replacement doses to treat identified deficiencies may become part of the armamentarium used in the ICU ‘toolkit’ in specific patient populations, but ongoing study is needed to determine the clinical utility of deficiency states and supplementation before universal screening is indicated in the ICU setting.

Acknowledgments

Copyright form disclosure:

Dr. Typpo’s institution received funding from the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases and from Baxter Corporation Investigator Initiated Grant with provision of study materials. She received support for article research from the NIH. Dr. Doctor’s institution received funding from the NIH, the Department of Defense, and the Children's Discovery Institute.

Contributor Information

Katri Typpo, Division of Critical Care Medicine University of Arizona, Tucson, AZ.

Allan Doctor, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri.

References

  1. Doctor A, Zimmerman J, Agus M, et al. Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2017;18:S67–S82. doi: 10.1097/PCC.0000000000001053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. 2.Suzuki AS, Berbel BT. Pediatric Multiple Organ Dysfunction Syndrome Promising Therapies: What about Vitamin D Supplementation? Pediatr Crit Care Med. 2017 doi: 10.1097/PCC.0000000000001202. in press. [DOI] [PubMed] [Google Scholar]
  3. 3.Putzu A, Belletti A, Cassina T, et al. Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials. Journal of critical care. 2017;38:109–14. doi: 10.1016/j.jcrc.2016.10.029. [DOI] [PubMed] [Google Scholar]
  4. 4.McNally JD, Menon K, Chakraborty P, et al. The association of vitamin D status with pediatric critical illness. Pediatrics. 2012;130:429–36. doi: 10.1542/peds.2011-3059. [DOI] [PubMed] [Google Scholar]
  5. 5.Shah SK, Kabra SK, Gupta N, Pai G, Lodha R. Vitamin D Deficiency and Parathyroid Response in Critically-ill Children: Association with Illness Severity and Clinical Outcomes. Indian pediatrics. 2016;53:479–84. doi: 10.1007/s13312-016-0876-2. [DOI] [PubMed] [Google Scholar]
  6. 6.Fowler AA, 3rd, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. Journal of translational medicine. 2014;12:32. doi: 10.1186/1479-5876-12-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. 7.Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, Vitamin C and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2016 doi: 10.1016/j.chest.2016.11.036. [DOI] [PubMed] [Google Scholar]
  8. 8.Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA : the journal of the American Medical Association. 2014;312:1520–30. doi: 10.1001/jama.2014.13204. [DOI] [PubMed] [Google Scholar]

RESOURCES